VaxInnate Updates Plans to Advance Lead Vaccine Candidate, VAX2012Q in Elderly Cranbury, NJ, Oct. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology platform, provided an update on clinical development plans for...